U.S. Hotel and Resort REITs Stock News

Banc of California came into this earnings print with a stock that has slipped over the past month yet edged up 1.65% to US$19.15 on the first full trading day after results. That small price lift sits awkwardly against a headline quarterly loss of US$251.3m and Basic EPS of US$1.61 in the red. The real story is not a slow bleed in the core franchise. It is a deliberate balance sheet hit, driven by a US$256.7m pretax loss on securities repositioning, that turns this quarter into a stress test...

MiMedx Group came into this earnings season with a rich valuation and a stock that had gained over the past quarter, yet the market clipped the share price about 3% to US$4.14 after the Q2 release. The gap is about profit quality. Revenue reached roughly US$64 million with clear momentum in surgical products, but the quarter flipped to a loss and the trailing net margin now sits at only 1.8%. For a stock trading on a high P/E multiple, that kind of margin squeeze is what investors reacted to...

MediaAlpha just saw its stock drop 8.6% to US$12.38, even though the company posted what it called record Q2 numbers. That clash between price and performance sets up a clear sentiment test for investors. The headline is simple: MediaAlpha delivered Q2 revenue of US$316.9m and basic earnings per share of US$0.73, both strong figures for a performance advertising marketplace. Yet the stock had already cooled in recent weeks and is now giving back more ground. The rest of this earnings story is...

AptarGroup stock barely budged after earnings, up just 0.1% to about $134, which indicates the market has not made a big call yet on this quarter. That calm surface hides a more complicated picture for a packaging and dispensing specialist that just posted roughly $1.0b in Q2 revenue and record quarterly sales. The key issue for long term holders is not the headline growth but the pressure under the hood. Adjusted EBITDA of $213 million came with a slimmer 20.7% margin, and that profit...

The market barely blinked at Omega Healthcare Investors after Q2 earnings, with the stock up just 0.5% over the session and still slightly down over the past week. That muted move sits awkwardly next to what actually drove the quarter. Adjusted funds from operations, the core cash flow metric for a real estate investment trust, held near US$0.83 per share while management inched full year adjusted FFO guidance higher and lifted the dividend by US$0.01. The real story is a sentiment standoff...

Teekay Tankers stock closed up 2.6% at US$79.37, which indicates traders reacted positively at first glance. The key point is the earnings power behind that move. Q2 basic earnings per share of US$6.49 and net income of US$225.9m came off the back of exceptionally strong spot charter rates, turning this quarter into a cash machine for a midsize tanker operator. For investors thinking beyond today’s move, the headline is simple: Teekay Tankers reported its highest adjusted quarterly profit on...

Gates Industrial Corporation Ltd. has already reported second‑quarter 2026 results, with sales rising to US$941.6 million and net income reaching US$170.9 million, alongside filing a Form 15 to voluntarily deregister its ordinary shares with the SEC. The combination of record earnings and the decision to deregister, following the closing of several ESOP-related shelf registrations, marks a major shift in how Gates Industrial accesses capital markets and manages shareholder...

Ventas stock was up 1.7% today, a modest move for a real estate investment trust that just reported a much bigger number. The market seems to be treating this as a routine beat. The quarterly increase in funds from operations to about US$493 million and a 9% rise in normalized funds from operations per share suggest a stronger story. For a senior housing heavy REIT, the key point is stronger cash generation from the same bricks and mortar. Same property cash net operating income climbed 10%...

AXT went into this print with a bruised share chart and a rich reputation, then ripped 28.7% higher to US$60.43 in a single session. The move followed a clear headline. The engineered materials company turned in record Q2 revenue of US$47.6m and swung back into profit with basic earnings per share of US$0.18. For a stock that had fallen 37% over the past three months before this jump, the surprise is less about hype and more about cash generation finally catching up to the high expectations...

In the past week, Butterfly Network, Inc. reported record second-quarter 2026 results, with revenue rising to US$32.61 million from US$23.38 million a year earlier and net loss narrowing to US$12.91 million, while also issuing third-quarter revenue guidance of US$26 million to US$30 million. The company raised its full-year 2026 revenue outlook to US$119 million–US$123 million, underpinned by very large Embedded segment growth, new partnerships, and improved gross margins. Next, we’ll...

PTC Therapeutics stock just dropped almost 10% in a single session, yet the quarter it reported is the sort of print that usually forces investors to rerun their models rather than hit the sell button. The company delivered Q2 2026 revenue of about US$360.5m and swung to roughly US$1.01 in basic earnings per share, a sharp turn from the small loss in Q1. That combination of strong top line and a move back into the black, set against a sliding share price, is the expectation gap that matters...

Xenia Hotels & Resorts stock ticked up about 2.5% to US$20.58 into the close, which suggests traders liked the headline as well as the story around it. The key reason is straightforward: management raised full year adjusted EBITDA for real estate guidance and pointed to stronger revenue per available room, the core health check for a hotel real estate investment trust. In the short term, that helps explain today’s move. Over the longer term, it prompts investors to weigh a richer earnings...

Check Point Software slipped less than 1% on the day, even though the earnings story is far more about quiet strength than drama. The stock came into this report with modest declines over the past week and month, yet Q2 showed solid cyber security fundamentals, including revenue of US$673.6m and basic earnings per share of US$1.88. Combined with a trailing P/E of 12.4x and a net margin of 37.9%, the reaction looks more like a shrug than a verdict. The real question now is how investors weigh...

In late July 2026, the U.S. government awarded Lockheed Martin a seven-year undefinitized contract action modification worth up to US$53.86 billion for PAC-3 Missile Segment Enhancement interceptors, expanding a multiyear agreement now totaling about US$58.62 billion and supporting capacity expansion and job growth at its Camden, Arkansas facility. This major long-term PAC-3 MSE award, alongside Lockheed Martin’s recent revenue and earnings growth and upgraded 2026 guidance, highlights how...

PBF Energy stock slipped 1.1% to US$72.28 even as the company reported one of the heaviest hitting refinery earnings results on the market this season. The headline is simple. Q2 delivered refinery level profits that put Basic EPS at US$7.66 and net income at US$906.4m, powered by strong crack spreads and tight product supply. The mood in the share price looks cautious. The financials read more like a sentiment stress test. Investors now have to decide whether this earnings power is a new...

Cohu stock snapped a rough month with a 3.3% jump to US$47.99, even though the longer 30 day stretch still leaves shares down sharply. The spark was not a return to big profits. The spark was how sharply the quarterly loss narrowed relative to recent history while revenue reached US$149.0m. The sentiment turning point is about one thing. The earnings squeeze that has weighed on Cohu for several quarters eased meaningfully, and the market quickly treated that margin relief as the headline, not...

Alnylam Pharmaceuticals just put up blockbuster TTR drug revenue while the stock barely moved. Shares closed at US$205.52, essentially flat on the day, even as second quarter net product sales reached about US$1.2b and global transthyretin amyloidosis revenue crossed US$1b in a single quarter for the first time. That muted one day reaction sits awkwardly against a company that is now solidly profitable on a trailing twelve month basis and posting several hundred million dollars of non GAAP...

Camping World Holdings slipped 1.8% to close at US$6.19, a muted reaction given the headline from Q2. The company swung back to profit with basic earnings per share of US$0.42 and net income of US$26.86 million, even as revenue held around US$1.9b in a still soft recreational vehicle retail market. The real story for long term investors is not this quarter’s rebound but whether that profit can outlast a tougher cycle. Management has cut adjusted EBITDA guidance and highlighted margin pressure...

Grand Canyon Education stock slipped about 3% to US$145.34 the day after its Q2 release, even though the core story was an earnings beat and firmer profitability. Adjusted diluted earnings per share landed at US$1.81, comfortably ahead of Wall Street expectations, and operating margin sat at 22% on US$264.0m of service revenue. For a company often framed as a slow, ex growth education services business, this quarter put the focus back on operational execution rather than the share price drift...

In late July 2026, Sunrun prepared to report quarterly results expected to show an earnings decline compared with a year earlier, even as revenue was projected to increase, with third‑party indicators pointing to a low likelihood of an upside surprise. This combination of weaker anticipated profitability alongside higher sales highlights the tension between Sunrun’s growth ambitions and the challenges of turning that growth into consistent earnings. Next, we’ll examine how the expected...

The market gave LSB Industries a small shrug. The stock slipped about 1.5% to US$10.88, even though the headline from this quarter is not about collapse but about a sharp profit squeeze. After a profitable Q1, LSB reported a basic loss per share of US$0.09 and a swing to a net loss of US$6.2m on roughly flat revenue near US$168m. That disconnect is the story. Price action hints at mild disappointment. The earnings print points to a much harsher reset in margins that investors now need to...

Madrigal Pharmaceuticals stock just dropped 5.2% on the day, yet the earnings story centers on a very different kind of pressure. The market is reacting to a headline loss, while the real strain sits in a widening profit gap created by heavy investment behind Rezdiffra and an expanding commercial footprint. Q2 net sales reached US$364.3m and trailing 12 month revenue hit about US$1.3b, strong figures for a mid stage biotech. Still, Madrigal Pharmaceuticals reported a Q2 net loss of US$57.9m...

Labcorp Holdings came into this earnings print with the stock quietly grinding higher over the past quarter, then gave back about 2% to close near US$309 as investors reacted to the headlines. The move masks what actually mattered. Q2 delivered higher revenue of US$3.7b and Basic EPS of US$3.66, alongside firmer profitability at the enterprise level. The real story is margin quality. Trailing net margin now sits at 7% versus 5.7% a year earlier, and management raised full year revenue and...

The market barely blinked at Mechanics Bancorp’s latest earnings, with the stock up about 1% today, yet the report carries more emotion than that quiet move suggests. You are looking at a bank that just printed Q2 net income of US$57.7m with basic earnings per share of about US$0.25 and a net interest margin of 3.62%. The real heartbeat is cost discipline. The cost to income ratio sits at 58.4%, and management is already talking about a leaner expense base ahead. The price reaction looks calm...